United Therapeutics | Actif À Court Terme





Actif À Court Terme Changement Date
Amarin USD 628.33M 21.52M 2025-09
Ardelyx USD 367.98M 16.42M 2025-09
Baxter International USD 6.87B 61M 2025-12
Bayer EUR 32.88B 873M 2025-09
BioCryst Pharmaceuticals USD 355.68M 42.78M 2025-09
Biogen USD 8.97B 37.5M 2025-12
BioMarin Pharmaceutical USD 3.85B 49.21M 2025-09
Emergent BioSolutions USD 679.5M 41.3M 2023-12
Esperion Therapeutics USD 360.46M 17.87M 2025-09
Gilead Sciences USD 19.89B 1.05B 2025-12
GlaxoSmithKline GBP 17.51B 332M 2025-12
Halozyme Therapeutics USD 825.21M 503.54M 2025-12
Insmed USD 1.79B 137.6M 2025-12
Ionis Pharmaceuticals USD 2.52B 58.16M 2025-09
J&J USD 55.62B 1.01B 2025-12
Lexicon Pharmaceuticals USD 145.08M 100.72M 2025-06
Moderna USD 6.54B 54M 2025-12
Omeros USD 69.65M 26.53M 2025-06
Pfizer USD 46.92B 3.22B 2025-09
PTC Therapeutics USD 2.27B 266.14M 2025-12
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Sarepta Therapeutics USD 2.72B 65.32M 2025-09
Teva Pharmaceutical Industries USD 13.95B 1.21B 2025-12
United Therapeutics USD 3.49B 332.9M 2025-09
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12


United Therapeutics Actif À Court Terme - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.